
Organovo Holdings ONVO
Quartalsbericht 2025-Q4
hinzugefügt 11.02.2026
Land |
|
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITAL |
Anteile |
1.46 M |
Marktkapitalisierung |
$ 19.4 M |
EBITDA (LTM) |
$ -13.7 M |
P/E (LTM) |
- |
P/S (LTM) |
168.58 |
EPS (LTM) |
-5.43 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Koninklijke Philips N.V.
PHG
|
$ 29.7 | 3.74 % | $ 20 B | NYSE | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 121.87 | 3.06 % | $ 37 B | NYSE,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 20.67 | -8.13 % | $ 222 M | Nasdaq Global Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
CareDx, Inc
CDNA
|
$ 21.42 | -4.46 % | $ 1.14 B | Nasdaq Global Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Co-Diagnostics
CODX
|
$ 1.56 | 6.85 % | $ 2.08 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Castle Biosciences
CSTL
|
$ 25.05 | 2.0 % | $ 696 M | Nasdaq Global Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Charles River Laboratories International
CRL
|
$ 183.88 | 3.92 % | $ 9.11 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Danaher Corporation
DHR
|
$ 194.75 | 0.5 % | $ 139 B | NYSE,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 2.0 | -9.09 % | $ 8.85 M | Nasdaq Global Select Market | ||
|
Myriad Genetics
MYGN
|
$ 5.08 | 1.6 % | $ 470 M | Nasdaq Global Select Market,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
NeoGenomics
NEO
|
$ 8.35 | 2.33 % | $ 1.07 B | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 9.51 | 2.92 % | $ 2.06 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 520.6 | 0.96 % | $ 15 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 134.5 | 1.34 % | $ 21.4 B | Nasdaq Global Select Market,SPB | ||
|
Precipio
PRPO
|
$ 28.3 | -2.41 % | $ 45.4 M | Nasdaq Global Select Market | ||
|
Fulgent Genetics
FLGT
|
$ 16.26 | 0.81 % | $ 492 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 90.36 | 5.44 % | $ 11.3 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 6.77 | - | $ 282 M | NYSE American | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Anixa Biosciences
ANIX
|
$ 2.91 | 2.83 % | $ 94.4 K | Nasdaq Capital Market | ||
|
Soleno Therapeutics
SLNO
|
$ 52.78 | 0.4 % | $ 2.68 B | Nasdaq Capital Market | ||
|
Biomerica
BMRA
|
$ 2.18 | -0.91 % | $ 5.01 M | Nasdaq Capital Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 119.68 | 3.55 % | $ 9.87 B | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 270.68 | 1.62 % | $ 22.5 B | NYSE,SPB | ||
|
Neuronetics
STIM
|
$ 1.42 | 1.43 % | $ 93.7 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 122.46 | -2.23 % | $ 5.73 B | Nasdaq Global Select Market | ||
|
Lantheus Holdings
LNTH
|
$ 83.82 | -0.12 % | $ 5.66 B | Nasdaq Global Select Market,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 526.6 | 2.05 % | $ 199 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.75 | 6.62 % | $ 61.9 M | Nasdaq Global Select Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 195.02 | 1.86 % | $ 21.6 B | NYSE,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 6.4 | 23.79 % | $ 5.04 M | Nasdaq Global Select Market |